Baddi

Alembic Limited, with an established presence in the Indian pharma  industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs1000 crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies. We continue to enjoy leadership positions in antibiotics, anti-infective, anti-cough and also have significant worldwide presence in specialty therapeutic areas such as cardiology, neurology, diabetology, etc.

Hygienic Research Institute (HRI) has come a long way since 1957, with an aim to satisfy the consumer’s needs in the modern world.
HRI wanted people to look and feel beautiful, naturally. Hence, every beauty product of HRI has been prepared with the help of modern technology and ancient Ayurvedic sciences, giving the consumer the very best, to be the very best.

Surya Pharmaceutical Limited { SPL) is one of the fastest growing pharmaceutical companies in India with an annual turnover of approx. Rs 1200 crores. One of the 20 largest Pharmaceutical Companies in the country, and ranked 398 in the prestigious FORTUNE 500 companies;

Post: Various Post in RnD, production, DRA, QC {find Below}

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, diversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Post: Executive QC

Solrex Pharmaceuticals is a leading Pharma Major, engaged in the formulation of Tablets, Capsules, Liquids & Ointments and our manufacturing plants are in operation at Himachal Pradesh, Madhya Pradesh, Goa & Punjab.

Post: Sr. Executive / Executive - Production, Pharma Formulations

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.